CD200 and B-cell chronic lymphocytic leukemia: Between June 2008 and December 2010, a Phase I clinical trial (NCT00648739) was conducted to evaluate the safety, pharmacology, and therapeutic efficacy of CD200/CD200R blockade in advanced CLL and multiple myeloma (MM) patients.